Literature DB >> 75549

Antithyroid drugs.

B Marchant, J F Lees, W D Alexander.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 75549     DOI: 10.1016/s0306-039x(78)80001-4

Source DB:  PubMed          Journal:  Pharmacol Ther B        ISSN: 0306-039X


× No keyword cloud information.
  14 in total

1.  Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.

Authors:  F A Karlsson; T H Tötterman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

2.  Are antithyroid drugs immunosuppressive?

Authors:  P Kendall-Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

3.  Specificity of the immunosuppressive action of carbimazole in Graves's disease.

Authors:  A M McGregor; B Rees Smith; R Hall; P N Collins; G Franco Bottazzo; M M Petersen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-12

4.  Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

Authors:  B Hallengren; O R Nilsson; B E Karlberg; A Melander; L Tegler; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Potentiation of glucose-induced insulin release by thiourea and thiourea derivatives.

Authors:  H P Ammon; M C Melien; T Pfäffle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

6.  Pharmacokinetic properties and bioavailability of methimazole.

Authors:  R Jansson; B Lindström; P A Dahlberg
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

7.  Thyrotoxicosis: changing trends in treatment.

Authors:  J Sheldon; D J Reid
Journal:  Ann R Coll Surg Engl       Date:  1986-09       Impact factor: 1.891

8.  Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.

Authors:  J Charreire; G Karsenty; P Bouchard; G Schaison
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Graves' disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil.

Authors:  K Sato; M Miyakawa; D C Han; S Kato; Y Shibagaki; T Tsushima; K Shizume
Journal:  J Endocrinol Invest       Date:  1985-12       Impact factor: 4.256

10.  The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients.

Authors:  G G Skellern; B I Knight; C K Low; W D Alexander; D G McLarty; W J Kalk
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.